Most Read Articles
2 days ago
High-frequency use of cannabis appears to worsen clinical pain and associated symptoms among chronic pain patients, a recent study has found.
Jairia Dela Cruz, 5 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Yesterday
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.

Spironolactone potentially chemopreventive in men

02 Sep 2020

Exposure to the diuretic spironolactone may reduce the risk of developing prostate cancer by about 17 percent, a study has found.

The study included 31,591 men with prostate cancer and 156,802 matched healthy controls. In total, 846 patients (3 percent) and 5,571 controls (4 percent) had been prescribed spironolactone, while 935 (3 percent) and 4,530 (3 percent), respectively, were exposed to thiazides. Use of diabetes medications was slightly lower among patients than controls.

Multivariable conditional logistic regression analyses revealed a lower risk of prostate cancer among individuals exposed to spironolactone (odds ratio [OR], 0.83, 95 percent confidence interval [CI], 0.76–0.89). The chemopreventive effect was more pronounced for current users (OR, 0.77, 95 percent CI, 0.69–0.86) than past users (OR, 0.88, 95 percent CI, 0.79–0.97) and with increasing dose intensity (p<0.001).

There was no association observed between thiazide exposure and prostate cancer risk.

Pointing out the biological plausibility of the results, the researchers said that spironolactone is structurally similar to progesterone, exerts antiandrogenic effects, and is sometimes used off-label to treat hyper-androgenic conditions such as hirsutism (excess female hair growth), adult acne, and polycystic ovary syndrome. Therefore, it is possible that spironolactone reduces prostate cancer risk via a similar mechanism involving androgen receptor blockade. [Heart Fail Rev 2005;10:23-29; Skinmed 2010;8:328-332; Clin Epidemiol 2013;6:1-13]

Alternatively, the results may be explained by a masking effect, whereby spironolactone lowers prostate-specific antigen (PSA) levels without affecting prostate cancer risk, the researchers added. Lower PSA levels could lead to fewer referrals for biopsy, and consequently, less opportunity for PCa detection. But in the current study, no evidence of increased risk of high grade or more advanced prostate cancer was seen among men exposed to spironolactone.

More studies are needed to investigate spironolactone’s potential chemopreventive effects.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
2 days ago
High-frequency use of cannabis appears to worsen clinical pain and associated symptoms among chronic pain patients, a recent study has found.
Jairia Dela Cruz, 5 days ago
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Yesterday
Women with pre-eclampsia are at higher risk of developing heart failure, a study suggests.
06 Sep 2020
Type 2 diabetes mellitus patients taking proton pump inhibitors (PPIs) are at a higher risk of sustaining hip fractures, a recent study has found.